miércoles, 20 de diciembre de 2023

European Medicines Agency & FDA Questions & Answers: Expediting Quality Development for FDA’s Breakthrough Therapies and EMA's PRIME Programs

https://www.fda.gov/drugs/pharmaceutical-quality-resources/european-medicines-agency-fda-questions-answers-expediting-quality-development-fdas-breakthrough?utm_medium=email&utm_source=govdelivery

No hay comentarios: